Science Corp
@science.xyz
Building a brighter tomorrow enabled by neural engineering
Science Founder and CEO, Max Hodak, has been named to 2026 @TIME 100 Health.
TIME writes: “It’s no small thing to bring eyesight to the blind—or nearly blind. But that’s what Max Hodak, founder and CEO of Science Corporation in California, has helped achieve.”
TIME writes: “It’s no small thing to bring eyesight to the blind—or nearly blind. But that’s what Max Hodak, founder and CEO of Science Corporation in California, has helped achieve.”
February 11, 2026 at 6:20 PM
Science Founder and CEO, Max Hodak, has been named to 2026 @TIME 100 Health.
TIME writes: “It’s no small thing to bring eyesight to the blind—or nearly blind. But that’s what Max Hodak, founder and CEO of Science Corporation in California, has helped achieve.”
TIME writes: “It’s no small thing to bring eyesight to the blind—or nearly blind. But that’s what Max Hodak, founder and CEO of Science Corporation in California, has helped achieve.”
In a new interview, Frank Holz, MD, lead author and scientific coordinator of the PRIMA clinical trial now published in @nejm.org, shares his opinion on the new reality of restoring vision to clinical trial patients who had been functionally blind.
February 9, 2026 at 4:02 PM
In a new interview, Frank Holz, MD, lead author and scientific coordinator of the PRIMA clinical trial now published in @nejm.org, shares his opinion on the new reality of restoring vision to clinical trial patients who had been functionally blind.
Frank Brodie, MD, Science’s Medical Director for Vision and PRIMA, joined @brightfocus.bsky.social to discuss the PRIMA retinal implant, the first treatment shown in clinical trials to restore functional vision for geographic atrophy due to AMD: www.brightfocus.org/resource/can...
Can Retinal Implants Restore Vision?
In this Macular Chats episode, we break down the different types of implants in development and look ahead to what’s next in the research pipeline.
www.brightfocus.org
February 5, 2026 at 5:00 PM
Frank Brodie, MD, Science’s Medical Director for Vision and PRIMA, joined @brightfocus.bsky.social to discuss the PRIMA retinal implant, the first treatment shown in clinical trials to restore functional vision for geographic atrophy due to AMD: www.brightfocus.org/resource/can...
Science founder and CEO @maxhodak.bsky.social sat down with the Berggruen Institute’s @futurologypod.bsky.social to discuss our work to improve the human condition.
Watch the full conversation here: youtu.be/1PlnrJ7t6AA
Watch the full conversation here: youtu.be/1PlnrJ7t6AA
February 4, 2026 at 4:49 PM
Science founder and CEO @maxhodak.bsky.social sat down with the Berggruen Institute’s @futurologypod.bsky.social to discuss our work to improve the human condition.
Watch the full conversation here: youtu.be/1PlnrJ7t6AA
Watch the full conversation here: youtu.be/1PlnrJ7t6AA
Frank Brodie, MD, Science’s Medical Director for Vision and PRIMA, will join @brightfocus.bsky.social for a discussion titled “Can Retinal Implants Restore Vision?”
Learn more about the conversation and how to join below.
Learn more about the conversation and how to join below.
January 27, 2026 at 9:38 PM
Frank Brodie, MD, Science’s Medical Director for Vision and PRIMA, will join @brightfocus.bsky.social for a discussion titled “Can Retinal Implants Restore Vision?”
Learn more about the conversation and how to join below.
Learn more about the conversation and how to join below.
In a @nejm.org editorial, Jacque Duncan, M.D. details the scientific foundations of PRIMA, describing it as the first treatment shown in clinical trials to successfully restore functional vision to certain patients suffering from geographic atrophy due to age-related macular degeneration.
Jacque Duncan, MD, describes the scientific foundations of restoring vision through the implantation of a retinal prosthetic chip in persons with geographic atrophy. Read the editorial: nej.md/4jP8uYs
#MedSky #Ophthalmology
#MedSky #Ophthalmology
January 26, 2026 at 6:32 PM
In a @nejm.org editorial, Jacque Duncan, M.D. details the scientific foundations of PRIMA, describing it as the first treatment shown in clinical trials to successfully restore functional vision to certain patients suffering from geographic atrophy due to age-related macular degeneration.
“We want to build tools that empower individuals to have agency over their life.”
In a video with the Abundance Institute, @maxhodak.bsky.social explains how neural engineering enables us to restore lost function and, in doing so, return agency to people who have lost it.
In a video with the Abundance Institute, @maxhodak.bsky.social explains how neural engineering enables us to restore lost function and, in doing so, return agency to people who have lost it.
The 50-Year History Of The Brain Computer Interface, Explained
YouTube video by Abundance Institute
www.youtube.com
January 21, 2026 at 10:51 PM
“We want to build tools that empower individuals to have agency over their life.”
In a video with the Abundance Institute, @maxhodak.bsky.social explains how neural engineering enables us to restore lost function and, in doing so, return agency to people who have lost it.
In a video with the Abundance Institute, @maxhodak.bsky.social explains how neural engineering enables us to restore lost function and, in doing so, return agency to people who have lost it.
Our PRIMA retinal implant is about the size of a pinhead and thinner than a human hair.
The chip “represents the first treatment to restore vision in persons with advanced geographic atrophy” in clinical trials, according to a new editorial in @nejm.org
The chip “represents the first treatment to restore vision in persons with advanced geographic atrophy” in clinical trials, according to a new editorial in @nejm.org
January 16, 2026 at 9:56 PM
Our PRIMA retinal implant is about the size of a pinhead and thinner than a human hair.
The chip “represents the first treatment to restore vision in persons with advanced geographic atrophy” in clinical trials, according to a new editorial in @nejm.org
The chip “represents the first treatment to restore vision in persons with advanced geographic atrophy” in clinical trials, according to a new editorial in @nejm.org
Ophthalmology Times reports on a @nejm.org editorial describing our PRIMA retinal implant as “the first treatment to restore vision” in clinical trials for certain patients with advanced geographic atrophy associated with age-related macular degeneration.
PRIMA retinal implant restores vision in patients with advanced GA | Ophthalmology Times - Clinical Insights for Eye Specialists
A total of 38 patients were included in the study. All underwent implantation of the PRIMAretinal prosthetic chip with the goal of restoring vision.
www.ophthalmologytimes.com
January 15, 2026 at 10:27 PM
Ophthalmology Times reports on a @nejm.org editorial describing our PRIMA retinal implant as “the first treatment to restore vision” in clinical trials for certain patients with advanced geographic atrophy associated with age-related macular degeneration.
An editorial published today in @nejm.org writes that our PRIMA implant is the first treatment in clinical trials to successfully restore functional vision to certain patients suffering from geographic atrophy due to age-related macular degeneration.
Read the editorial: www.nejm.org/doi/full/10....
Read the editorial: www.nejm.org/doi/full/10....
www.nejm.org
January 14, 2026 at 11:32 PM
An editorial published today in @nejm.org writes that our PRIMA implant is the first treatment in clinical trials to successfully restore functional vision to certain patients suffering from geographic atrophy due to age-related macular degeneration.
Read the editorial: www.nejm.org/doi/full/10....
Read the editorial: www.nejm.org/doi/full/10....
“Blind patients are actually able to have meaningful central vision restoration, which has never been done before.” – Mahi Muqit, PhD, co-author of the New England Journal of Medicine paper, discussing clinical trial results of our PRIMA retinal implant
A Revolutionary Device Can Cure Blindness. This Has ‘Never Been Done Before,’ Researcher Says.
Thanks to this tiny piece of tech, people with profound vision loss can now read, do cross word puzzles, and navigate public transit.
www.popularmechanics.com
January 12, 2026 at 6:43 PM
“Blind patients are actually able to have meaningful central vision restoration, which has never been done before.” – Mahi Muqit, PhD, co-author of the New England Journal of Medicine paper, discussing clinical trial results of our PRIMA retinal implant
Our PRIMA retinal implant is designed to replace the function of light-sensitive cells in the eye that have been lost due to advanced degenerative retinal diseases, restoring functional central vision in clinical trials
Here's what the world looks like to a PRIMA patient science.xyz/technologies...
Here's what the world looks like to a PRIMA patient science.xyz/technologies...
January 8, 2026 at 11:46 PM
Our PRIMA retinal implant is designed to replace the function of light-sensitive cells in the eye that have been lost due to advanced degenerative retinal diseases, restoring functional central vision in clinical trials
Here's what the world looks like to a PRIMA patient science.xyz/technologies...
Here's what the world looks like to a PRIMA patient science.xyz/technologies...
In clinical trials, our PRIMA retinal implant restored functional vision to patients suffering from geographic atrophy due to age-related macular degeneration.
Take a look inside the labs.
Take a look inside the labs.
December 23, 2025 at 9:36 PM
In clinical trials, our PRIMA retinal implant restored functional vision to patients suffering from geographic atrophy due to age-related macular degeneration.
Take a look inside the labs.
Take a look inside the labs.
At a recent Stanford Icons dinner, @maxhodak.bsky.social shared his perspective on neural engineering and the future of brain–computer interfaces—from biohybrid neural interfaces built with living neurons to the long-term pursuit of conscious machines.
Max Hodak, Science Founder, Neuralink Co-Founder and ex-President
Becoming Limitless
svicons.com
December 19, 2025 at 3:58 PM
At a recent Stanford Icons dinner, @maxhodak.bsky.social shared his perspective on neural engineering and the future of brain–computer interfaces—from biohybrid neural interfaces built with living neurons to the long-term pursuit of conscious machines.
Today we announced Vessel, a project focused on rethinking perfusion from the ground up.
Our founder and CEO @maxhodak.bsky.social spoke with @wired.com’s @emilymullin.bsky.social about how neural interfaces and Vessel are both longevity technologies, and that is the goal of Science.
Our founder and CEO @maxhodak.bsky.social spoke with @wired.com’s @emilymullin.bsky.social about how neural interfaces and Vessel are both longevity technologies, and that is the goal of Science.
Former Neuralink Exec Launches Organ Preservation Effort
Science Corporation, founded by Neuralink’s first president, Max Hodak, has unveiled a prototype machine to extend the life of organs for longer periods.
www.wired.com
December 17, 2025 at 6:27 PM
Today we announced Vessel, a project focused on rethinking perfusion from the ground up.
Our founder and CEO @maxhodak.bsky.social spoke with @wired.com’s @emilymullin.bsky.social about how neural interfaces and Vessel are both longevity technologies, and that is the goal of Science.
Our founder and CEO @maxhodak.bsky.social spoke with @wired.com’s @emilymullin.bsky.social about how neural interfaces and Vessel are both longevity technologies, and that is the goal of Science.
As we work to restore, improve, and extend life, we are making important leadership appointments.
Alan Mardinly will serve as our first Chief Scientific Officer.
Frank Brodie, M.D. will serve as Medical Director for Vision and PRIMA.
Alan Mardinly will serve as our first Chief Scientific Officer.
Frank Brodie, M.D. will serve as Medical Director for Vision and PRIMA.
Science Announces Key Scientific Leadership Appointments; Welcomes New Chief Strategy Officer | Science Corporation
Science Corporation is a clinical-stage medical technology company.
science.xyz
December 11, 2025 at 7:18 PM
As we work to restore, improve, and extend life, we are making important leadership appointments.
Alan Mardinly will serve as our first Chief Scientific Officer.
Frank Brodie, M.D. will serve as Medical Director for Vision and PRIMA.
Alan Mardinly will serve as our first Chief Scientific Officer.
Frank Brodie, M.D. will serve as Medical Director for Vision and PRIMA.
Welcome Darius Shahida, our new Chief Strategy Officer.
As we continue to accelerate into our mission to transcend the limits of biology, Darius brings deep experience in strategic growth, capital markets, and scaling category-defining technology companies.
Read the press release in the comments.
As we continue to accelerate into our mission to transcend the limits of biology, Darius brings deep experience in strategic growth, capital markets, and scaling category-defining technology companies.
Read the press release in the comments.
BCI maker Science Corp. taps former Butterfly Network exec as new chief strategy officer
Brain-computer interface (BCI) company Science Corp. announced that it appointed Darius Shahida as its new chief strategy officer (CSO).
www.massdevice.com
December 11, 2025 at 5:05 PM
Welcome Darius Shahida, our new Chief Strategy Officer.
As we continue to accelerate into our mission to transcend the limits of biology, Darius brings deep experience in strategic growth, capital markets, and scaling category-defining technology companies.
Read the press release in the comments.
As we continue to accelerate into our mission to transcend the limits of biology, Darius brings deep experience in strategic growth, capital markets, and scaling category-defining technology companies.
Read the press release in the comments.
@techcrunch.com's @connieloizos.bsky.social highlights our founder and CEO @maxhodak.bsky.social’s path from early brain–machine interface research to how his perspective continues to shape our approach to neural engineering.
After Neuralink, Max Hodak is building something even wilder | TechCrunch
"You could really, in a very fundamental sense, talk about redrawing the border around a brain," Hodak says, "possibly to include four hemispheres, or a device, or a whole group of people."
techcrunch.com
December 9, 2025 at 12:08 AM
@techcrunch.com's @connieloizos.bsky.social highlights our founder and CEO @maxhodak.bsky.social’s path from early brain–machine interface research to how his perspective continues to shape our approach to neural engineering.
Science founder and CEO @maxhodak.bsky.social joined @connieloizos.bsky.social at @techcrunch.com’s StrictlyVC in Palo Alto to explore the future of neural engineering – from restoring vision to building technologies that could reshape how humans think, learn, and interface with the world.
Brain-computer interfaces are coming faster than you think | StrictlyVC Palo Alto
YouTube video by TechCrunch
www.youtube.com
December 5, 2025 at 9:36 PM
Science founder and CEO @maxhodak.bsky.social joined @connieloizos.bsky.social at @techcrunch.com’s StrictlyVC in Palo Alto to explore the future of neural engineering – from restoring vision to building technologies that could reshape how humans think, learn, and interface with the world.
In our clinical trial, participants with geographic atrophy experienced something previously thought impossible: meaningful restoration of central vision.
Learn more about our PRIMA retinal implant here: science.xyz/technologies...
Learn more about our PRIMA retinal implant here: science.xyz/technologies...
December 5, 2025 at 12:42 AM
In our clinical trial, participants with geographic atrophy experienced something previously thought impossible: meaningful restoration of central vision.
Learn more about our PRIMA retinal implant here: science.xyz/technologies...
Learn more about our PRIMA retinal implant here: science.xyz/technologies...
What could you do with world-class neurotech that fits in the palm of your hand?
The Science Ecosystem has the hardware and software needed to develop next-generation neural engineering therapies.
Learn more here: science.xyz/company/cont...
The Science Ecosystem has the hardware and software needed to develop next-generation neural engineering therapies.
Learn more here: science.xyz/company/cont...
November 25, 2025 at 8:12 PM
What could you do with world-class neurotech that fits in the palm of your hand?
The Science Ecosystem has the hardware and software needed to develop next-generation neural engineering therapies.
Learn more here: science.xyz/company/cont...
The Science Ecosystem has the hardware and software needed to develop next-generation neural engineering therapies.
Learn more here: science.xyz/company/cont...
We are neuroscientists, biologists, cell engineers, electrical engineers, mechanical engineers, software engineers, IC designers, MEMS engineers, clinicians, operators, and more.
We are Science.
Learn more about our work here: science.xyz
We are Science.
Learn more about our work here: science.xyz
November 24, 2025 at 9:22 PM
We are neuroscientists, biologists, cell engineers, electrical engineers, mechanical engineers, software engineers, IC designers, MEMS engineers, clinicians, operators, and more.
We are Science.
Learn more about our work here: science.xyz
We are Science.
Learn more about our work here: science.xyz
Thank you to the many scientists, physicians, and researchers who visited us at the Society for Neuroscience’s (@sfn.org) Annual Meeting 2025 and shared their excitement for our work building a brighter tomorrow enabled by neural engineering.
If you missed us at #SfN25, learn more here: science.xyz
If you missed us at #SfN25, learn more here: science.xyz
November 21, 2025 at 12:24 AM
Thank you to the many scientists, physicians, and researchers who visited us at the Society for Neuroscience’s (@sfn.org) Annual Meeting 2025 and shared their excitement for our work building a brighter tomorrow enabled by neural engineering.
If you missed us at #SfN25, learn more here: science.xyz
If you missed us at #SfN25, learn more here: science.xyz
We develop a full range of technologies required for modern neural engineering, building devices aimed at restoring vision, communication and cognition to improve the human condition.
Visit us at Booth #3101 at the Society for Neuroscience’s (@sfn.org) Annual Meeting 2025 to learn more. #SfN25
Visit us at Booth #3101 at the Society for Neuroscience’s (@sfn.org) Annual Meeting 2025 to learn more. #SfN25
November 19, 2025 at 5:05 PM
A first glimpse from #SfN2025: our next-gen PRIMA glasses.
The glasses feature an embedded camera and infrared projector that send light signals to our PRIMA retinal implant, providing both power and data.
Experience the PRIMA glasses and preview the next-generation design at Booth #3101.
The glasses feature an embedded camera and infrared projector that send light signals to our PRIMA retinal implant, providing both power and data.
Experience the PRIMA glasses and preview the next-generation design at Booth #3101.
November 18, 2025 at 8:21 PM
A first glimpse from #SfN2025: our next-gen PRIMA glasses.
The glasses feature an embedded camera and infrared projector that send light signals to our PRIMA retinal implant, providing both power and data.
Experience the PRIMA glasses and preview the next-generation design at Booth #3101.
The glasses feature an embedded camera and infrared projector that send light signals to our PRIMA retinal implant, providing both power and data.
Experience the PRIMA glasses and preview the next-generation design at Booth #3101.